PD-1 drugs for Merkel Cell Carcinoma
2 tracked PD-1 drugs in the Merkel Cell Carcinoma race. The class explanation lives on the PD-1 page; the full indication pipeline across every mechanism is on the Merkel Cell Carcinoma page.
2 approved / phase 4
Head-to-head evidence: Pembrolizumab vs Retifanlimab